ReviewIranian journal of public health2023
Efficacy and Safety of Nintedanib in Patients with Interstitial Lung Disease with or without Systemic Sclerosis: A Meta-Analysis.
Young Ho Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.